2-Ethyl-6-(2-pyridyl)-5,6,6a,11b-tetrahydro-7H-indeno[2,1-c]quinoline
Open Access
- 20 February 2010
- journal article
- research article
- Published by International Union of Crystallography (IUCr) in Acta Crystallographica Section E Crystallographic Communications
- Vol. 66 (3) , o680-o681
Abstract
The title compound, C(23)H(22)N(2), was obtained using the three-component imino Diels-Alder reaction via a one-pot condensation between anilines, α-pyridine-carboxy-aldehyde and indene using BF(3)·OEt(2) as the catalyst. The mol-ecular structure reveals the cis-form as the unique diastereoisomer. The crystal structure comprises one-dimensional zigzag ribbons connected via N-H⋯N hydrogen bonds. C-H⋯π inter-actions also occur.Keywords
This publication has 12 references indexed in Scilit:
- Structure validation in chemical crystallographyActa Crystallographica Section D Structural Biology, 2009
- A short history of SHELXActa Crystallographica Section A Foundations of Crystallography, 2007
- Topoisomerase I inhibitors: camptothecins and beyondNature Reviews Cancer, 2006
- Transformations of 2-(α-Furyl)- 4-(2-Oxopyrrolidinyl-1)-1,2,3,4-Tetrahydroquinolines, Cycloadducts of the Imino Diels-Alder Reaction: A Simple Synthesis of New Quinoline DerivativesLetters in Organic Chemistry, 2006
- Review Camptothecin: Current PerspectivesCurrent Medicinal Chemistry, 2006
- The Search of DNA-Intercalators as Antitumoral Drugs: What it Worked and What did not WorkCurrent Medicinal Chemistry, 2005
- Self-association and unique DNA binding properties of the anti-cancer agent TAS-103, a dual inhibitor of topoisomerases I and IIBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2002
- Phase I Clinical and Pharmacogenetic Study of Weekly TAS-103 in Patients With Advanced CancerJournal of Clinical Oncology, 2001
- Phase I and pharmacokinetic study of DACA (XR5000): a novel inhibitor of topoisomerase I and IIBritish Journal of Cancer, 1999
- A Dual Topoisomerase Inhibitor, TAS-103, Induces Apoptosis in Human Cancer CellsJapanese Journal of Cancer Research, 1999